Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Middleton

Showing results (31-40 of 550) with videos related to

Pageof 55
Sort By:
Kidney International|August 30, 2014
Prescriptions for dietary sodium in patients with chronic kidney disease: how will this shake out?John P Middleton, Ruediger W Lehrich
Seminars in Dialysis|August 6, 2015
Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor AntagonistsSamantha Dias Suthar, John P Middleton
Kidney International|April 16, 2010
Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacyJohn P Middleton, Patrick H Pun
Journal of the American Society of Nephrology : JASN|October 11, 2017
Dialysate Potassium, Dialysate Magnesium, and Hemodialysis RiskPatrick H Pun, John P Middleton
BMJ (Clinical Research Ed.)|August 5, 2003
Breast cancer in menGeorge H Perkins, Lavinia P Middleton
Visual Neuroscience|July 13, 2011
Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cellsT P Middleton, D A Protti
Advances in Chronic Kidney Disease|December 3, 2014
The need for collaboration to improve cardiovascular outcomes in patients with CKDJohn P Middleton, Uptal D Patel
The Cochrane Database of Systematic Reviews|October 21, 2006
Intrapartum interventions for preventing shoulder dystociaC Athukorala, P Middleton, C A Crowther
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Forskolin increases the rate of acetylcholine receptor desensitization at rat soleus endplatesP Middleton, F Jaramillo, S M Schuetze
The Medical Journal of Australia|February 6, 1998
Medical editors trial amnestyM B Van Der Weyden, P Middleton
Pageof 55

Showing results (31-40 of 550) with videos related to

Sort By:
Pageof 55
Kidney International|August 30, 2014
Prescriptions for dietary sodium in patients with chronic kidney disease: how will this shake out?John P Middleton, Ruediger W Lehrich
Seminars in Dialysis|August 6, 2015
Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor AntagonistsSamantha Dias Suthar, John P Middleton
Kidney International|April 16, 2010
Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacyJohn P Middleton, Patrick H Pun
Journal of the American Society of Nephrology : JASN|October 11, 2017
Dialysate Potassium, Dialysate Magnesium, and Hemodialysis RiskPatrick H Pun, John P Middleton
BMJ (Clinical Research Ed.)|August 5, 2003
Breast cancer in menGeorge H Perkins, Lavinia P Middleton
Visual Neuroscience|July 13, 2011
Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cellsT P Middleton, D A Protti
Advances in Chronic Kidney Disease|December 3, 2014
The need for collaboration to improve cardiovascular outcomes in patients with CKDJohn P Middleton, Uptal D Patel
The Cochrane Database of Systematic Reviews|October 21, 2006
Intrapartum interventions for preventing shoulder dystociaC Athukorala, P Middleton, C A Crowther
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Forskolin increases the rate of acetylcholine receptor desensitization at rat soleus endplatesP Middleton, F Jaramillo, S M Schuetze
The Medical Journal of Australia|February 6, 1998
Medical editors trial amnestyM B Van Der Weyden, P Middleton
Pageof 55